Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
8.56M
-
Number of holders
-
106
-
Total 13F shares, excl. options
-
56M
-
Shares change
-
+7.75M
-
Total reported value, excl. options
-
$791M
-
Value change
-
+$105M
-
Put/Call ratio
-
0.46
-
Number of buys
-
78
-
Number of sells
-
-40
-
Price
-
$14.12
Significant Holders of Atara Biotherapeutics, Inc. - Common Stock (ATRA) as of Q3 2019
142 filings reported holding ATRA - Atara Biotherapeutics, Inc. - Common Stock as of Q3 2019.
Atara Biotherapeutics, Inc. - Common Stock (ATRA) has 106 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 56M shares
.
Largest 10 shareholders include BAUPOST GROUP LLC/MA (8.31M shares), MAVERICK CAPITAL LTD (5.1M shares), Redmile Group, LLC (4.52M shares), BlackRock Inc. (4.45M shares), VANGUARD GROUP INC (3.58M shares), Camber Capital Management LP (2.95M shares), BRIDGER MANAGEMENT, LLC (2.66M shares), STATE STREET CORP (2.61M shares), JPMORGAN CHASE & CO (2.58M shares), and FEDERATED INVESTORS INC /PA/ (2.23M shares).
This table shows the top 106 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.